Our CEO, Simranjit Singh was recently featured in BioSpectrum Asia’s online magazine where he shared insights into the liquid biopsy market and how our Guardant360 test can help guide treatment decisions for advanced stage cancer patients with solid tumors. https://lnkd.in/ePW9Vkz
Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at email@example.com or contact us on WhatsApp: +65 8940 0360.
Guardant360®. Test. Take Action.